TPGS2000-DOX prodrug micelles for improving BC therapy

TPGS2000-DOX prodrug micelles reverse the MDR of tumor cells, achieve passive targeting by forming nanomicelles, & enhance the efficacy & reduce DOC toxicity.

Related Keywords

Dalian ,Liaoning ,China ,Germany ,Japan ,Shanghai ,United States ,Zhejiang ,Ling Feng ,Switzerland ,Ludwigshafen ,Rheinland Pfalz ,Hangzhou ,Nanjing ,Jiangsu ,Chinese , ,Laboratory Animals ,Genome Biomedical Technology Co Ltd ,Shanghai Ling Feng Chemical Reagent Co Ltd ,Becton Dickinson ,Institute Of Laboratory Animal Research ,Shanghai Silaike Experimental Animal Co Ltd ,Cell Bank ,Chinese Academy Of Sciences ,Dalian Meilun Biological Technology Co Ltd ,Perkinelmer ,Aladdin Reagent Co Ltd ,Beckman Coulter ,Corporation Ludwigshafen ,Keygen Biotechnology Co Ltd ,Shanghai Covalent Chemistry ,Chinese Academy ,Animal Care ,Ethics Committee ,Zhejiang Technology University ,Permit Number ,Laboratory Animal ,Malvern Zetasizer Instruments ,Drug Release ,Resistant Index ,Reversal Factor ,Cell Cycle ,